Author:
Brabander Tessa,Teunissen Jaap J.M.,Van Eijck Casper H.J.,Franssen Gaston J.H.,Feelders Richard A.,de Herder Wouter W.,Kwekkeboom Dik J.
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Reference58 articles.
1. Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group;Rinke;J Clin Oncol,2009
2. Phase I study of peptide receptor radionuclide therapy with [In-DTPA0]octreotide: the Rotterdam experience;Valkema;Semin Nucl Med,2002
3. Indium-111-pentetreotide prolongs survival in gastroenteropancreatic malignancies;Anthony;Semin Nucl Med,2002
4. Effects of therapy with [177Lu-DOTA0, Tyr3] octreotate in patients with paraganglioma, meningioma, small cell lung carcinoma, and melanoma;Van Essen;J Nucl Med,2006
5. Somatostatin receptor-targeted radiopeptide therapy with 90Y-DOTATOC and 177Lu-DOTATOC in progressive meningioma: long-term results of a phase II clinical trial;Marincek;J Nucl Med,2015
Cited by
54 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献